Skip to main content
Molimo sačekajte...

UTICAJ ANTIHIPERTENZIVNE TERAPIJE, UNOSA NATRIJUMA I KONCENTRACIJE KALIJUMA U PLAZMI NA KONCENTRACIJU ALDOSTERONA I PLAZMA RENINSKU AKTIVNOST

Reference
Kronenberg HK, Melmed S, Polonsky KS, Larsen PR, eds. 2008. Williams textbook of endocrinology. 11th ed. Philadelphia, PA: Saunders; 505–537.
Funder JW, Carey RM, Fardella C et al. Case Detection, Diagnosis, and Treatment of Patients with Primary Aldosteronism: An Endocrine Society Clinical Practice Guideline. J. Clin. Endocrinol. Metab. 2008; 93:3266–3281.
Hannemann A, Bidlingmaier M, Friedrich N. Screening for primary aldosteronism in hypertensive subjects: results from two German epidemiological studies. Eur J Endocrinol. 2012; 167:7–15.
Jazika rada
Medicinski glasnik

LEKOVI, TIREOSTIMULIŠUĆI HORMON I CENTRALNI HIPOTIREOIDIZAM

E-mail
medsto@eunet.rs
Ustanova
Klinika za endokrinologiju, dijabetes i bolesti metabolizma, KC Vojvodine
Reference
Surks MI, Sievert R. Drugs and thyroid function. New England Journal of Medicine, 1995, 333 (25): 1688–1694.
Lania A, Persani L, Beck-Peccoz P. Central Hypothyreoidism.Pituitary, 2008, 11: 181–186.
Bryan RH. Drugs that supress TSH or cause central hypothyreoidizam. Best Practice&Research Clinical Endocrinology & Metabolism, 2009, 23: 793–800.
Jazika rada
Medicinski glasnik